These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 24889740)

  • 1. Hepatitis C virus treatment revolution: need for close monitoring.
    Ippolito G; Antonelli G; Capobianchi MR; Lanini S
    Clin Microbiol Infect; 2014 Nov; 20(11):O790-1. PubMed ID: 24889740
    [No Abstract]   [Full Text] [Related]  

  • 2. Ribavirin in chronic hepatitis C: past and future.
    Loustaud-Ratti V; Rousseau A; Marquet P; Denis F; Alain S
    Expert Rev Anti Infect Ther; 2009 Apr; 7(3):249-53. PubMed ID: 19344238
    [No Abstract]   [Full Text] [Related]  

  • 3. Telaprevir for chronic HCV infection.
    van der Meer AJ; de Knegt RJ
    N Engl J Med; 2009 Jul; 361(5):533-4; author reply 534-5. PubMed ID: 19641215
    [No Abstract]   [Full Text] [Related]  

  • 4. [Studies with boceprevir].
    MMW Fortschr Med; 2011 Jul; 153(29-31):16. PubMed ID: 21830728
    [No Abstract]   [Full Text] [Related]  

  • 5. Monitoring response to antiviral therapy for patients with chronic hepatitis C virus infection by a core-antigen assay.
    Rebucci C; Cerino A; Cividini A; Timo L; Furione M; Mondelli MU
    J Clin Microbiol; 2003 Aug; 41(8):3881-4. PubMed ID: 12904409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient reappearance of serum hepatitis C virus RNA observed by real-time PCR during antiviral therapy with peginterferon and ribavirin: Reappearance of references published in 2005-2009.
    Gelderblom HC; Beld MG
    J Clin Virol; 2010 Jun; 48(2):150-1; author reply 152. PubMed ID: 20347385
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparable performance of TMA and Real-Time PCR in detecting minimal residual hepatitis C viraemia at the end of antiviral therapy.
    Bortoletto G; Campagnolo D; Mirandola S; Comastri G; Severini L; Pulvirenti FR; Alberti A
    J Clin Virol; 2011 Mar; 50(3):217-20. PubMed ID: 21195023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twelve week post-treatment undetectable hepatitis C virus (HCV)-RNA by PCR assay predicts a sustained virological response to anti-HCV therapy independently from immunological status of the infected patients.
    Donato MF; Bastiampillai AJ; Manini M; Monico S
    J Antimicrob Chemother; 2013 Apr; 68(4):974-5. PubMed ID: 23221629
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of patients with chronic hepatitis C who have not been previously treated].
    Marcellin P; Boyer N
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B194-201. PubMed ID: 12180288
    [No Abstract]   [Full Text] [Related]  

  • 10. New proposal for response-guided peg-interferon-plus-ribavirin combination therapy for chronic hepatitis C virus genotype 2 infection.
    Abe H; Aida Y; Ishiguro H; Yoshizawa K; Seki N; Miyazaki T; Itagaki M; Sutoh S; Ika M; Kato K; Shimada N; Tsubota A; Aizawa Y
    J Med Virol; 2013 Sep; 85(9):1523-33. PubMed ID: 23775277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expensiveness of hepatitis C virus polymerase inhibitor sofosbuvir: a warrant for therapeutic drug monitoring of compliance.
    Colson P; Gérolami R
    Clin Microbiol Infect; 2015 Apr; 21(4):e32. PubMed ID: 25658571
    [No Abstract]   [Full Text] [Related]  

  • 12. Cost effectiveness of direct-acting antiviral therapy for treatment-naive patients with chronic HCV genotype 1 infection in the veterans health administration.
    Chan K; Lai MN; Groessl EJ; Hanchate AD; Wong JB; Clark JA; Asch SM; Gifford AL; Ho SB
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1503-10. PubMed ID: 23707354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individualisation of antiviral therapy for chronic hepatitis C.
    Teoh NC; Farrell GC; Chan HL
    J Gastroenterol Hepatol; 2010 Jul; 25(7):1206-16. PubMed ID: 20594246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Naturopathy consultation. Soon all patients will be curable. Decisive breakthrough in therapy of hepatitis C ].
    Einecke D
    MMW Fortschr Med; 2014 Feb; 156(3):26-7. PubMed ID: 24938054
    [No Abstract]   [Full Text] [Related]  

  • 15. Infectious diseases. First specific drugs raise hopes for hepatitis C.
    Enserink M
    Science; 2011 Apr; 332(6026):159-60. PubMed ID: 21474720
    [No Abstract]   [Full Text] [Related]  

  • 16. Chronic hepatitis C in children is a mild and curable liver disease.
    Di Marco V
    Dig Liver Dis; 2011 Apr; 43(4):266-7. PubMed ID: 21353653
    [No Abstract]   [Full Text] [Related]  

  • 17. Approach to the treatment-naïve patient with HCV genotype 1 infection.
    Muir AJ
    Infect Dis Clin North Am; 2012 Dec; 26(4):893-901. PubMed ID: 23083822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of hepatitis C virus--2012: a real breakthrough].
    Zuckerman E
    Harefuah; 2012 Dec; 151(12):699-704, 719. PubMed ID: 23330264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Not Available].
    Stingl W
    MMW Fortschr Med; 2015 Jun; 157 Suppl 2():55. PubMed ID: 26048126
    [No Abstract]   [Full Text] [Related]  

  • 20. [New triple therapy in chronic hepatitis C. Increased patient chances].
    Stiefelhagen P
    MMW Fortschr Med; 2011 Sep; 153(39):20. PubMed ID: 21991830
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.